LEMAITRE VASCULAR INC business relationships
Companies named in LEMAITRE VASCULAR INC’s 10-K filed 2026-02-26, and public companies whose annual reports name LEMAITRE VASCULAR INC. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 3.6 / 10
- AI naming
- <1 / 100 Top 34% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in LEMAITRE VASCULAR INC’s annual report 0
No company named in this filing matched a company in the map.
Companies whose annual reports name LEMAITRE VASCULAR INC 2
“Such sales have historically been made principally to 4C and to LeMaitre Vascular, Inc. ("LeMaitre"), a distributor of medical products, to whom we sold the distribution rights for CardioCel™ and VascuCel™ in 2019 in order to focus on development of our proprietary ADAPT ® tissue for the DurAVR ® TH...” SEC filing
“In April 2023, we entered into an exclusive distribution agreement with LeMaitre Vascular for these products in the United States.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.